penicillamine has been researched along with Dyslipidemias in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruguera-Àvila, N | 1 |
Sánchez-Martínez, E | 1 |
Garcia-Olivé, I | 1 |
Pérez-Ochoa, JF | 1 |
Martínez-Barenys, C | 1 |
Ruiz-Manzano, J | 1 |
1 other study available for penicillamine and Dyslipidemias
Article | Year |
---|---|
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modal | 2013 |